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Abstract
Background:  Therapeutic biliary procedures disrupt the function of the sphincter of Oddi.
Patients are potential "bile refluxers". The aim of this study was to assess how these procedures
affect the histology-based bile reflux index (BRI), which can be used to reflect duodenogastric reflux
(DGR).
Methods: Gastric antrum and corpus biopsies were collected from 131 subjects (56 men, 75
women; mean age, 55.9 ± 15.6 years). Group 1 (Biliary group-BG; n = 66) had undergone
endoscopic sphincterotomy, endoscopic stenting, or choledochoduodenostomy for benign
pathology; Group 2 (n = 20) had undergone cholecystectomy alone; and Group 3 (n = 6) Billroth
II gastroenterostomy. Group 4 (no cholecystectomy; n = 39) had upper endoscopy with normal
findings and served as controls. BRI > 14 indicated DGR (BRI [+]). To eliminate confounding effects
of Helicobacter pylori (Hp) infection, comparisons were made according to Hp colonization.
Results: Fifty-nine subjects (45%) were Hp (+). The frequencies of BRI (+) status in antrum and
corpus specimens from Hp (-) BG patients were 74.3% and 71.4%, respectively (85.7% for both
antrum and corpus for choledochoduodenostomy). Corresponding results were 60% and 60% for
Group 2, 100% (only corpus) for Group 3, and 57.1% and 38.1% for controls (BG, Group 2, and
Group 3 vs controls – p > 0.05 antrum, p < 0.05 corpus). Fifty-four BG patients had previously
undergone cholecystectomy. Excluding those, the rates of BRI (+) in Hp (-) BG patients were 75%
antrum and 62.5% corpus (p > 0.05 for both vs. Group 2).
Conclusion:  Patients who had undergone biliary procedures showed similar bile-related
histological changes in both corpus and antrum biopsies, but the changes seen in controls were
more prominent in the antrum than corpus. Therapeutic biliary procedures increase the rate of
BRI (+) especially in the case of choledochoduodenostomy. Therapeutic biliary procedures without
cholecystectomy also increase the rate of BRI (+) similar to that observed in patients with
cholecystectomy.
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Background
Duodenogastric reflux (DGR) is a poorly understood gas-
trointestinal process that is defined as reflux of duodenal
contents into the stomach. It is very common for this con-
dition to develop in adults who have undergone gastric
surgery, pyloroplasty or cholecystectomy [1,2]. Duode-
nogastroesophageal reflux (DGER) is the disorder in
which material from the duodenum passes into the stom-
ach and the esophagus. Many recent studies have focused
on the effects of DGR and DGER. Bile and duodenal con-
tents have chronic noxious effects in both the stomach
and the esophagus. Long-term exposure can cause dyspla-
sia, intestinal metaplasia, ulcers and malignancy in the
stomach, and Barrett's esophagus and various forms of
esophageal malignancy [3].
The underlying mechanisms and motor events involved
in DGR are not clear [3,4]. Researchers have looked at the
anatomical impacts of pyloroplasty and Billroth II gastro-
enterostomy, gastric and duodenal motor function, and
interactions among these processes. Motor coordination
of the stomach, pylorus and duodenum, concentration of
duodenal contents, and food intake have been identified
as important factors in the development of DGR [4].
It is not clear whether functional and anatomic integrity of
the sphincter of Oddi plays a role in DGR. Many patients
who need therapeutic biliary procedures undergo endo-
scopic sphincterotomy, stent insertion, or choledochodu-
odenostomy and then continue life with a dysfunctional
sphincter of Oddi. Such biliary procedures disrupt the
control of bile flow into the duodenum, making these
patients potential "refluxers". Currently, biliary reflux is
usually measured with a fiberoptic spectrophotometer
(Bilitec®). However, Sobala et al. [5] developed a histo-
logic index that identifies DGR based on several findings:
edema in the lamina propria, intestinal metaplasia (IM),
chronic inflammation, and gastric Helicobacter pylori (Hp)
infection. In this system, a histological bile reflux index
(BRI) value above 14 indicates the presence of DGR.
The aim of this study was to investigate how therapeutic
biliary procedures, which disrupt the function of the
sphincter of Oddi, affect the gastric histology according to
BRI.
Methods
The subjects for this prospective study were the patients
who presented to our endoscopic retrograde cholangio-
pancreatography (ERCP) and endoscopy unit for investi-
gation/treatment of various benign pathologies between
April 2003 and October 2003. The reasons for visiting the
unit included cholangitis, need for stent exchange, com-
mon bile duct stones, and benign biliary stricture. Exclu-
sion criteria were history of alcohol abuse or portal
hypertension, current use of a non-steroidal anti-inflam-
matory drug or any anticoagulant or antiaggregant, and
presence of acute pancreatitis. Each subject was assigned
to 1 of 4 groups and tissue specimens were collected
(details below). Group 1 patients (biliary group [BG]; n =
66) had undergone at least one of the following proce-
dures for treatment of benign pathology: endoscopic
sphincterotomy (ES), endoscopic stenting, or choledo-
choduodenostomy. The other patients had undergone
cholecystectomy only (Group 2; n = 20) or Billroth II gas-
troenterostomy (Group 3; n = 6). Group 4 patients (con-
trols; n = 39) had no history of cholecystectomy but had
undergone upper endoscopy for dyspepsia or reflux-like
symptoms and had normal findings. The BG was divided
into 3 subgroups based on the type of biliary procedure
performed: ES and stenting (BG1), ES alone (BG2), and
choledochoduodenostomy (BG3). All subjects were histo-
logically evaluated for Hp infection, and history or not of
cholecystectomy was noted for each BG patient. All
patients provided written informed consent for the proce-
dures and those who agreed to enter the study were
enrolled; the ethical approval for this study was obtained
from the Gastroenterology Clinical Council
ECRP was performed using a TJF-240 duodenoscope
(Olympus, Japan) and upper gastrointestinal endoscopy
was performed with a QX10 esophagogastroduodeno-
scope (Olympus, Japan). During the procedure, 2 biopsies
were obtained from the gastric antrum and 2 from the cor-
pus. A pathologist (GA) who was blinded to the patients'
clinical findings assessed each gastric tissue sample
according to the above-mentioned BRI system devised by
Sobala et al. [5]. In this system, an index is derived based
on the presence/severity of certain histological parame-
ters: edema (denoted as E in the formula below) in the
lamina propria, intestinal metaplasia (IM), chronic
inflammation (CI in the formula below), and Hp coloni-
zation in the stomach. For every specimen, the pathologist
assigned a grade from 0 to 3 (representing absent, mild,
moderate, or marked, respectively) for each histological
parameter. An index value was then calculated using a for-
mula derived from stepwise logistic regression analysis:
BRI = (7 × E)+(3 × IM)+(4 × CI)-(6 × Hp).
According to Sobala and colleagues, a BRI above 14 indi-
cates DGR (defined as bile acid level > 1 mmol/L [the
upper limit of physiological reflux]) with 70% sensitivity
and 85% specificity.
For analysis, any antrum or corpus specimen with BRI
above 14 was identified as BRI (+). For each patient, the
average BRIs for the 2 antrum specimens and for the 2 cor-
pus specimens were calculated. The frequencies of antrum
BRI (+) and corpus BRI (+) were then calculated for eachBMC Gastroenterology 2008, 8:4 http://www.biomedcentral.com/1471-230X/8/4
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patient group and for each BG subgroup. To eliminate the
confounding effects of Hp infection on gastric mucosa,
comparisons were made according to Hp colonization sta-
tus. Analysis was also done to test for factors that can
affect BRI (+) status, such as patient age and the interval
from therapeutic procedure (ES, cholecystectomy, others)
to biopsy collection. Group rates of cholecystectomy, IM,
and  Hp  colonization were also separately evaluated in
relation to age.
Statistical analysis was done using the Statistical Package
for Social Sciences (SPSS for Windows, v. 11.0.0). Chi-
square was used to compare the group frequencies of BRI
(+) status. Regarding the other factors listed above, the
Student t test was used to compare results for parametric
variables and the Mann-Whitney U test to compare results
for nonparametric variables. Results were expressed as
mean ± standard deviation and p values less than 0.05
were considered statistically significant.
Results
A total of 131 patients (56 men and 75 women; mean age
55.9 ± 15.6 years) were included in the study. Tables 1
lists demographic features and Hp colonization status for
the patient groups and BG subgroups. Of the 131 patients,
59 (45%) were Hp (+). There were no significant differ-
ences among Groups 1, 2, 3 and 4 with respect to sex dis-
tribution, age or Hp (+) status.
Table 2 shows the frequencies of BRI (+) status (for
antrum and corpus specimens separately) in each patient
group as a whole and in the proportion of each group that
was  Hp  (-). The frequencies of BRI (+) status for the
antrum and corpus biopsies from the BG group and the
corresponding frequencies for the Hp (-) individuals from
this group were all higher than the corresponding values
in the control group; however, only the differences
between the corresponding corpus values were significant.
The patients who had undergone Billroth II procedures
(Group 3) had the highest BRI (+) frequencies (100% BRI
[+] in Group 3 as a whole and same for the Hp [-] patients;
all 6 in this group were Hp [-]). However, analysis exclud-
ing this group revealed that the frequencies of BRI (+) sta-
tus in the corpus specimens from all patients in the BG
(48.5%) and in Group 2 (cholecystectomy only; 35%),
and from the proportions of these groups that were Hp (-
) (71.4% and 60%, respectively) were significantly higher
than the corresponding rates in the control group (23.1%
for whole group, 38.1% for Hp [-] portion) (p < 0.05 for
all). The frequencies of BRI (+) status for the antrum and
corpus specimens from the Hp (-) individuals in the BG
were both higher than the corresponding values in Group
2, but these differences were not statistically significant
(71.4% vs. 60%, respectively, for corpus; 74.3% vs. 60%,
respectively, for antrum; p > 0.05 for both).
Table 3 shows the frequencies of BRI (+) status in each BG
subgroup as a whole and in the proportion of each sub-
group that was Hp (-). The Hp (-) portion of the choledo-
choduodenostomy subgroup (BG3) had the highest
frequencies of BRI (+) status (85.7% for corpus, 85.7% for
antrum). Most patients in the BG (54 of 66) had under-
gone cholecystectomy. When these individuals were
excluded from the analysis, the frequencies of BRI (+) sta-
tus in the antrum and corpus biopsies from Hp (-) patients
in the BG were 75% and 62.5%, respectively. These values
were not significantly different from the corresponding
results in the Hp (-) patients of Group 2 (60% and 60%,
respectively) (p > 0.05 for both).
Differences between frequencies of antrum BRI (+) status
and corpus BRI (+) status in each group were also com-
pared. In the BG, these differences were not significant
(45.5% vs. 48.5%, respectively, for BG as a whole; 74.3%
vs. 71.4%, respectively, for the Hp (-) portion; p > 0.05 for
both). In Group 2, the frequencies of antrum and corpus
BRI (+) status were 60% and 35% for the group as a
whole, and 60% and 60% for the Hp (-) portion. Neither
of these differences was significant (p > 0.05 for both). In
Group 4, the frequencies of antrum and corpus BRI (+)
status were 41% and 23%, respectively, for the entire
group and 57.1% and 38.1%, respectively, for the Hp (-)
portion (p > 0.05 for both).
The mean intervals from initial procedure to time of
biopsy in BG1 (ES+stenting), BG2 (ES alone), and BG3
Table 1: Demographic characteristics and H. pylori colonization status in the 4 patient groups and Group 1 subgroups.
N Age (y) (mean ± SD) Cholecystectomy No. Hp(+) N (%)
Group 1 66 55.4 ± 13.6 54 (81.8) 31 (47)
BG1 (ES+stent) 28 52.7 ± 12.5 23 (82.1) 13 (46.4)
BG2 (ES only) 23 55.2 ± 15.3 16 (69.7) 10 (43.5)
BG3 (Choledochoduodenostomy) 15 60 ± 11.9 15 (100) 8 (53.3)
Group 2 Cholecystectomy 20 64 ± 11.8 20 (100) 10/20 (50)
Group 3 Billroth II 6 62.8 ± 13.6 2 (33.3) 0 (0)
Group 4 Controls 39 51.4 ± 19.3 0 (0) 18 (46.2)
BG: Biliary group. ES: Endoscopic sphincterotomy.BMC Gastroenterology 2008, 8:4 http://www.biomedcentral.com/1471-230X/8/4
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(choledochoduodenostomy) were 20.8 ± 21.2 months
(range, 3–85 months; median, 13 months), 23.9 ± 35.1
months (range, 0.2–144 months; median, 11 months),
and 61.3 ± 77.8 months (range, 2–300 months; median,
41 months), respectively. In Group 2, the interval from
cholecystectomy to biopsy was 85.3 ± 112.5 months
(range, 1.2–384 months; median, 60 months). Analysis of
the BG subgroups and Group 2 revealed no relationship
between BRI (+) status in the specimens (antrum and cor-
pus samples analyzed separately) and interval from proce-
dure to biopsy (p  > 0.05 for both antrum and corpus
samples; Mann-Whitney U test).
The mean ages of the 131 subjects were compared accord-
ing to BRI (+) and BRI (-) status in the antrum and corpus,
and were determined as 58.9 ± 15.4 years vs 52.6 ± 15.5
years for antrum (p = 0.023) and 60.3 ± 14.1 years vs 52.8
± 16.1 years for corpus (p = 0.007), respectively. In both
categories of results, the BRI (+) status group had a signif-
icantly higher mean age.
Other factors linked with BRI (+) status were not found to
change with age. When the mean ages of the 131 patients
were determined in groups divided according to presence
of IM (in antrum and corpus specimens separately [62.6 ±
12.8 years vs 52.7 ± 16.1 years; 61.6 ± 13.3 years vs 54.6 ±
15.9 years]), Hp colonization (55.2 ± 14.8 years vs 56.5 ±
16.4 years), and history of cholecystectomy (57.3 ± 13.7
years vs 53.9 ± 18.1 years), no significant differences were
determined. Analysis revealed that the patients with IM
(+) antrum and corpus specimens were older than those
with IM (-) antrum and corpus specimens, but the differ-
ences were not significant.
Discussion
Healthy individuals have anatomical and functional bar-
riers that restrict increased intestinal reflux. The pylorus
and the physiologically correct angle between the duode-
num and the bulbus are the main anatomical factors.
Antroduodenal motility, pyloric motility, and coordina-
tion of these activities are the main functional factors. The
exact mechanisms of DGR are not known. This type of
reflux is a physiological phenomenon that occurs post-
prandially and during sleep [6-9], but in some situations
it becomes pathologic. This can occur, for example, after
gastric surgery [10,11] or cholecystectomy [12-15]. The
healthy gastrointestinal tract has numerous mechanisms
that defend against secretions, which are normally found
in the lumen. However, proximal reflux of duodenal juice
can damage unprotected mucosa [16]. Research has
revealed much evidence that duodenal juice has noxious
effects when it occurs in abnormal sites or accumulates in
massive amounts [17-23]. As noted, therapeutic biliary
procedures impair the function of the sphincter of Oddi,
leading to uncontrolled flow of bile into the duodenum.
These patients are prone to DGR. Only a few studies have
evaluated the effects of therapeutic biliary procedures on
DGR and the results are conflicting. Fountos et al. [24]
investigated using scintigraphy and found that DGR is
common after biliary surgery (cholecystectomy or chole-
cystectomy-choledochoduodenostomy) and procedures
such as ES. They did not evaluate the Hp status of their
Table 2: Frequencies of BRI (+) status for antrum (A) and corpus (C) biopsies in the 4 patient groups, with results listed for all patients 
in each group and for the proportion that was Hp (-).
BRI(+) A biopsies in 
total group (%)
BRI(+) A biopsies in 
Hp(-) (%)
BRI(+) C biopsies in 
total group (%)
BRI(+) C biopsies in 
Hp(-) (%)
Group 1 (Biliary group) 30/66 (45.5) 26/35 (74.3) 32/66 (48.5) 25/35 (71.4)
Group 2 Cholecystectomy 12/20 (60) 6/10 (60) 7/20 (35) 6/10 (60)
Group 3 Billroth II - - 6/6 (100) 6/6 (100)
Group 4 Controls 16/39 (41) 12/21 (57.1) 9/39 (23.1) 8/21 (38.1)
p > 0.05 > 0.05 0.001 0.017
BRI: Bile reflux index.
Table 3: Frequencies of BRI (+) status for antrum (A) and corpus (C) biopsies in the 3 study group (BG) subdivisions, with results listed 
for all patients in each subdivision and for the proportion that was Hp (-).
BRI(+) A biopsies in 
total group (%)
BRI(+) A biopsies in 
Hp(-) (%)
BRI(+) C biopsies in 
total group (%)
BRI(+) C biopsies in 
Hp(-) (%)
BG1 ES+stent 10/28 (35.7) 10/15 (66.7) 14/28 (50) 12/15 (80)
BG2 ES only 11/23 (47.8) 10/13 (76.9) 9/23 (39.1) 7/13 (53.8)
BG3 
Choledochoduodenostomy
9/15 (60) 6/7 (85.7) 9/15 (60) 6/7 (85.7)
p > 0.05 > 0.05 > 0.05 > 0.05
BRI: Bile reflux index. BG: Biliary group. ES: Endoscopic sphincterotomy.BMC Gastroenterology 2008, 8:4 http://www.biomedcentral.com/1471-230X/8/4
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patients. Tritapepe et al. [25] also investigated with scin-
tigraphy and observed that choledochoduodenostomy
did not increase DGR, whereas transduodenal sphinctero-
plasty did. Di Vita and colleagues [26] used scintigraphy
to assess DGR in 23 patients (sphincterotomy performed
in 16; choledochoduodenostomy in 7). They detected
DGR in only 1 patient who had undergone sphincterot-
omy, but in almost all those who had undergone choledo-
choduodenostomy. In all these studies, scintigraphy was
used to assess DGR and the impact of Hp infection was
not evaluated. In our research, we used histological BRI to
assess DGR. Our data indicate that therapeutic biliary pro-
cedures increase the frequency of BRI (+) status especially
in choledochoduodenostomy.
It is difficult to diagnose DGR. Reports note conflicting
results with respect to histopathologic changes in the gas-
tric mucosa of these patients. Stein and colleagues [27]
investigated the diagnostic value of gastric histology rela-
tive to degree of DGR and found a poor correlation. In
contrast, Dixon et al. [17] used the histological BRI and
detected a strong correlation between this index and gas-
tric bile acid levels. Dixon and other co-workers (Sobala et
al. [5]) had introduced their BRI system in a previous
study, detailing the derivation of this index by stepwise
logistic regression analysis of histological grades of vari-
ous factors (edema, IM, chronic inflammation, Hp coloni-
zation). The later work by Dixon et al. [17] revealed that
patients with Barrett's esophagus exhibit more evidence of
bile-related gastritis than those with gastroesophageal
reflux disease or non-ulcer dyspepsia. In an even more
recent study, Dixon et al. [18] found that IM at the cardia
was associated with histological evidence of bile reflux
into the stomach. The Bilitec® device is the best method for
monitoring bilirubin levels in the esophagus; however,
interpretation of gastric bilirubin is more complex and
Bilitec® is not as accurate in this setting [28-30]. Also, the
value of measuring bilirubin is that high bilirubin levels
indicate possible histologic changes in affected mucosa.
The BRI is derived from observed changes in tissue histol-
ogy and is, thus, an important tool that can reflect
mucosal changes caused by bilirubin.
In our study, the frequencies of BRI (+) status in antrum
and corpus biopsies from BG patients were similar to the
corresponding rates in Group 2 (cholecystectomy only).
Most of the BG patients (54 of 66) had undergone chole-
cystectomy. The BG subgroups who had undergone ES or
stenting in addition to cholecystectomy had somewhat
higher frequencies of BRI (+) status than Group 2 (chole-
cystectomy only), but these differences were not signifi-
cant. Only the choledochoduodenostomy subgroup
(BG3) had significantly higher frequencies of BRI (+) in
both corpus and antrum biopsies when compared to
Group 2. After choledochoduodenostomy, the opening of
the common bile duct is located more proximal to the
bulbus than its original site, and the angle at which it
opens into the duodenum is changed. This anatomical
alteration can lead to increased frequency of BRI (+) sta-
tus. In Group 1 (BG), 54 patients had undergone chole-
cystectomy in addition to other therapeutic biliary
procedures and the other 12 had undergone the therapeu-
tic procedure(s) alone (no cholecystectomy) (Table 1).
Within the latter group of 12, the frequency of BRI (+) sta-
tus in the individuals who were Hp (-) was similar to that
observed in the Hp (-) portion of Group 2. These results
suggest that performing therapeutic biliary procedures in
patients who have already undergone cholecystectomy
increases the likelihood of BRI (+) status, but therapeutic
biliary procedures alone also increased the BRI (+) status
as much as observed in patients who had cholecystec-
tomy. Thus, therapeutic biliary procedures are a risk factor
for increased frequency of BRI (+) status.
We also looked at relationships between various parame-
ters in this study. The analysis indicated that, for patients
who undergo ES, endoscopic stenting, choledochoduode-
nostomy or cholecystectomy, there is no relationship
between the time at which the procedure is performed
and BRI (+) status. In contrast, our results for age identi-
fied this as an important factor in the histological BRI sys-
tem. The patients with BRI (+) status were significantly
older than those who were BRI (-). A few previous studies
have tested links between age and DGR. Bollschweiler et
al. [31] evaluated bile reflux into the stomach and esopha-
gus in a population of volunteers older than 40 years.
They found no significant difference in reflux into the
stomach when patients were grouped according to age
(younger [median age 25 years] vs. older [median age 51
years]). Byrne and co-workers [32] also observed no link
between age and DGR. In both of these studies, the
Bilitec® method was used to measure levels of DGR. In
contrast, our findings using the histological BRI system
indicated that BRI (+) status is more common in older
than in younger individuals.
Our findings related to age made it essential to evaluate
factors that can change with age, such as Hp colonization
status, history of cholecystectomy, and presence of IM. We
observed no significant differences in mean age when our
131 subjects were divided according to Hp colonization
status (Hp [+] vs. Hp [-]) or according to history of chole-
cystectomy. When patients were categorized according to
presence of IM in antrum and corpus specimens (sepa-
rately), there were no significant differences between the
mean ages of the groups with and without IM in both the
antrum and the corpus.BMC Gastroenterology 2008, 8:4 http://www.biomedcentral.com/1471-230X/8/4
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Conclusion
In conclusion, DGR is an important gastroenterological
process that needs to be more fully understood. The goal
of this study was to evaluate how various therapeutic bil-
iary procedures affect the histology of the stomach. Our
results indicate that therapeutic biliary procedures, espe-
cially choledochoduodenostomy, can be a risk factor for
increased DGR. We also observed that, compared to con-
trols, patients who had undergone biliary procedures
showed similar bile-related histological changes in the
corpus and the antrum. One would normally expect to
find a higher level of bile in the antrum than in the corpus.
Interestingly, in the groups/subgroups in our study that
were at higher risk for increased DGR (i.e., patients with
history of cholecystectomy, or those who had undergone
cholecystectomy plus therapeutic biliary procedures), the
frequency of increased DGR in the corpus was similar to
that in the antrum. This suggests that bile reflux causes
more marked histologic disturbances in the proximal
stomach than in more distal areas. Our results also suggest
that older patients and those who are Hp (-) are at higher
risk for developing increased DGR.
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